Royal Bank of Canada’s OS Therapies Inc OSTX Stock Holding History

Royal Bank of Canada’s Portfolio OSTX Stock Details OSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-480	Closed	-$1K	–	7776
2025 Q4	$1K	Buy	+480	New	+$866	﹤0.01%	7067

Other funds holding OSTX

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HFS

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada's OSTX Position: Q1 2026 in Review

Royal Bank of Canada sold out of OS Therapies Inc (OSTX) in Q1 2026, closing a stake of 480 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in OSTX in Q4 2025 and held it in 1 quarter. The position peaked at $1K in Q4 2025. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

Royal Bank of Canada reported no remaining OS Therapies Inc position as of Q1 2026 after selling out during the quarter.
Royal Bank of Canada sold 480 OS Therapies Inc shares in Q1 2026, an estimated $1K.
Royal Bank of Canada first reported a position in OS Therapies Inc in Q4 2025 and held it in 1 quarter.
Royal Bank of Canada's OS Therapies Inc position peaked at $1K in Q4 2025.
29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.